Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-03-14 Cappello Joseph VP, Pharmaceutical Development Grant or award +11,557 20,953
2024-03-14 Yu Yong VP, Clinical Trial Operations Grant or award +11,557 17,718
2024-03-14 Ryder Sean General Counsel Grant or award +9,270 22,778
2024-03-14 Jewett Caroline Head of Quality Grant or award +3,612 25,890
2024-02-19 Zindrick Thomas President and CEO Grant or award +8,320 22,971
2024-02-19 Zak Lourie S. Chief Financial Officer Grant or award +1,220 32,470
2024-02-19 Smalling Ralph Head of Regulatory Grant or award +616 13,931
2024-02-19 Cappello Joseph VP, Pharmaceutical Development Grant or award +3,661 9,396
2024-02-19 Yu Yong VP, Clinical Trial Operations Grant or award +3,661 6,161
2024-02-19 Ryder Sean General Counsel Grant or award +2,936 13,508
2024-02-19 Jewett Caroline Head of Quality Grant or award +1,143 22,278
2023-12-15 Yu Yong VP, Clinical Trial Operations Sale −26,732 $12.94 $346K 5,803
2023-12-15 Yu Yong VP, Clinical Trial Operations Sale −5,803 $14.18 $82K 0
2023-12-13 Tyree James L Director Sale −5,653 $12.91 $73K 6,807
2023-12-13 Tyree James L Director Sale −3,347 $13.73 $46K 3,460
2023-12-13 Thomas John Director Sale −7,073 $13.23 $94K 465,387
2023-12-13 Thomas John Director Sale −1,927 $13.93 $27K 463,460
2023-12-07 Yu Yong VP, Clinical Trial Operations Sale −36,800 $11.85 $436K 32,535
2023-11-21 Yu Yong VP, Clinical Trial Operations Sale −18,665 $10.26 $192K 69,335
2023-11-20 Yu Yong VP, Clinical Trial Operations Sale −14,594 $11.26 $164K 88,000

Page 10 of 16 · 315 trades